You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

end of treatment response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Left Ventricular Assist Device Patients

Completed
  • End-stage Heart Failure
  • +2 more
  • VerifyNow antiplatelet therapy response test
  • Vienna, Austria
    Medical University of Vienna
Nov 28, 2023

Obesity Associated Disorder Trial in Giza (respiratory parameters on mechanical ventilator (PEEP))

Completed
  • Obesity Associated Disorder
  • respiratory parameters on mechanical ventilator (PEEP)
  • Giza, Egypt
    Al Kasr Al Aini Teaching Hospital
Aug 19, 2022

Ventilator-Induced Lung Injury, Sepsis Syndrome, Mechanical Ventilation Complication Trial in New York (PEEP (positive

Recruiting
  • Ventilator-Induced Lung Injury
  • +2 more
  • PEEP (positive end-expiratory pressure) - maximum
  • PEEP (positive end-expiratory pressure) - standard
  • New York, New York
    Columbia University
Jul 28, 2023

Immune System of End Stage Kidney Disease on Dialysis and Kidney

Recruiting
  • End Stage Kidney Disease
  • +3 more
  • SARS - COV 2 VACCINE
  • Ioannina, Epirus, Greece
    Evangelia Ntounousi
Sep 28, 2021

Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic

Not yet recruiting
  • Hepatic Encephalopathy
  • +2 more
    • Chandigarh, India
      Postgraduate Institute of Medical Education and Research
    Jun 13, 2022

    Multimorbidity - End-stage Kidney Disease Trial (Aerobic exercise, Control)

    Completed
    • Multimorbidity - End-stage Kidney Disease
    • Aerobic exercise
    • Control
    • Sherbrooke, Quebec, Canada
    • +1 more
    Oct 31, 2022

    End Stage Renal Disease Trial in Nashville (dietary supplement, drug, behavioral)

    Not yet recruiting
    • End Stage Renal Disease
    • CoQ10
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center-GCRC
    Jun 13, 2022

    Acute on Chronic Liver Failure Trial in New Delhi (Carvedilol 12.5 MG)

    Recruiting
    • Acute on Chronic Liver Failure
    • Carvedilol 12.5 MG
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences
    Jan 7, 2022

    Respiratory Failure Trial in Milan (PEEP trial - Electrical Impedance Tomography)

    Recruiting
    • Respiratory Failure
    • PEEP trial - Electrical Impedance Tomography
    • Milan, MI, Italy
      Ospedale Maggiore Policlinico
    Nov 23, 2021

    End-stage Kidney Disease Trial in Brampton, Toronto (SUPPORT-DIALYSIS with Access to Output Report and Information Hub,

    Not yet recruiting
    • End-stage Kidney Disease
    • SUPPORT-DIALYSIS with Access to Output Report and Information Hub
    • SUPPORT-DIALYSIS Only
    • Brampton, Ontario, Canada
    • +1 more
    Aug 22, 2022

    End Stage Renal Disease Trial in Sacramento (Etanercept, Placebo)

    Terminated
    Has Results
    • End Stage Renal Disease
    • Sacramento, California
      University of California, Davis, Medical Center
    Jul 12, 2021

    Neuroblastoma Trial in New York (anti-GD2 murine IgG3 mAb 3F8)

    Completed
    Has Results
    • Neuroblastoma
    • anti-GD2 murine IgG3 monoclonal antibody 3F8
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Apr 21, 2022

    Breast Cancer Trial in France (procedure, drug, radiation)

    Recruiting
    • Breast Cancer
    • Immediate mammary reconstruction
    • +2 more
    • Marseille, Bouches-du-Rhône, France
    • +9 more
    Jun 30, 2020

    Renal Disease Trial in Coventry

    Completed
    • Renal Disease
      • Coventry, Warwickshire, United Kingdom
        UHCW
      Feb 19, 2020

      Alopecia Areata Trial in United States (CTP-543, Placebo)

      Active, not recruiting
      • Alopecia Areata
      • Birmingham, Alabama
      • +38 more
      Jul 26, 2022

      Lupus Nephritis Trial in Worldwide (BI 655064, Placebo)

      Completed
      Has Results
      • Lupus Nephritis
      • BI 655064
      • Placebo
      • Plantation, Florida
      • +35 more
      Jun 21, 2022

      Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

      Not yet recruiting
      • Stage III Non-small Cell Lung Cancer
      • +2 more
      • standard Radiotherapy
      • +3 more
      • (no location specified)
      Oct 20, 2023

      Hepatitis C Virus Infection, Response to Therapy of Trial in Cairo (Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER])

      Withdrawn
      • Hepatitis C Virus Infection, Response to Therapy of
      • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
      • Cairo, Almanial, Egypt
        Kasr Alainy Hospital
      Apr 16, 2020

      Longitudinal, Prospective, French, Multicenter Cohort Study on

      Not yet recruiting
      • Pancreatic Tumor
      • Pancreatic radiofrequency
      • (no location specified)
      May 15, 2023

      Fluid Responsiveness in Septic Shock Patients, Can End-tidal co2

      Recruiting
      • Septic Shock
      • +2 more
      • End-tifdal co2, systolic, diastolic blood pressure, ppv values and vci distensibility
      • Izmir, Karabağlar, Turkey
        UHS Izmir Bozyaka Education and Research Hospital
      Jan 23, 2023

      Crohn's Disease Trial in Worldwide (Guselkumab, Placebo)

      Not yet recruiting
      • Crohn's Disease
      • Phoenix, Arizona
      • +82 more
      Jun 20, 2023

      Bariatric Surgery Candidate Trial in Alexandria (protective lung strategy with recruitment manoeuvre (RM) - steady PEEP,

      Completed
      • Bariatric Surgery Candidate
      • protective lung strategy with recruitment manoeuvre (RM) - steady PEEP
      • protective lung strategy with recruitment manoeuvre (RM) - decreasing PEEP
      • Alexandria, Egypt
        Alexandria University Faculty of Medicin
      Jul 18, 2023

      Multiple Myeloma Trial in Denmark, Ireland (Isatuximab, Bortezomib, Lenalidomide)

      Recruiting
      • Multiple Myeloma
      • Aarhus, Denmark
      • +5 more
      Jul 29, 2022

      Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, Early Stage, Anlotinib Trial in Guangzhou (Sintilimab)

      Completed
      • Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
      • +7 more
      • Guangzhou, Guangdong, China
        Sun Yat-Sen University Cancer Center
      Jun 6, 2022

      Hirsuitism Trial in Abbottabad (IPL, Diode)

      Completed
      • Hirsuitism
      • IPL
      • Diode
      • Abbottābād, Kpk, Pakistan
        Sara Ilyas
      Feb 13, 2023